CSO | Dr. Vincent Vuaroqueaux, PhD

Vincent Vuaroqueaux has been working in translational cancer research for 25 years. Prior to joining 4HF Biotec in January 2017, Vincent headed the department of biomarker development and bioinformatics at Oncotest/Charles River Laboratories (2011-2016). Vincent holds diplomas in cellular biology, and genetics from the University of Aix-Marseille where he earned his PhD by studying targetability and clinical impact of various gastrointestinal peptides and their receptors in CRC. He did next a postdoc at the APH-Marseille (2000-2002) to introduce molecular biology technics for assessment of  clinical biomarkers. Vincent has then occupied leadership positions at Oncoscore, Stiftung Tumor Bank Basel (2002-2007) and at Oncotest AG (2007-2011)  for the development of predictive and prognostic companion diagnostics. Vincent is member of the AACR since 2011.

CSO | Dr. Vincent Vuaroqueaux, PhD

Vincent Vuaroqueaux has been working in translational cancer research for 25 years. Prior to joining 4HF Biotec in January 2017, Vincent headed the department of biomarker development and bioinformatics at Oncotest/Charles River Laboratories (2011-2016). Vincent holds diplomas in cellular biology, and genetics from the University of Aix-Marseille where he earned his PhD by studying targetability and clinical impact of various gastrointestinal peptides and their receptors in CRC. He did next a postdoc at the APH-Marseille (2000-2002) to introduce molecular biology technics for assessment of  clinical biomarkers. Vincent has then occupied leadership positions at Oncoscore, Stiftung Tumor Bank Basel (2002-2007) and at Oncotest AG (2007-2011)  for the development of predictive and prognostic companion diagnostics. Vincent is member of the AACR since 2011.